TArgeting Type 1 Diabetes Using POLyamines (TADPOL)

NCT05594563 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: DFMO
DRUG: Placebo

Sponsor

Emily K. Sims

Collaborators

[object Object]
[object Object]